Moloney Securities Asset Management LLC Has $245,000 Stock Position in Cigna Group $CI

Moloney Securities Asset Management LLC cut its holdings in shares of Cigna Group (NYSE:CI) by 8.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 740 shares of the health services provider’s stock after selling 72 shares during the period. Moloney Securities Asset Management LLC’s holdings in Cigna Group were worth $245,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the business. Valeo Financial Advisors LLC grew its holdings in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after acquiring an additional 3,471,249 shares during the period. Nuveen LLC acquired a new stake in shares of Cigna Group during the first quarter worth $727,905,000. Price T Rowe Associates Inc. MD increased its holdings in Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. GQG Partners LLC lifted its stake in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in Cigna Group by 38.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after buying an additional 457,052 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 1.1%

NYSE:CI opened at $301.84 on Friday. The company has a market cap of $80.57 billion, a P/E ratio of 16.48, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. Cigna Group has a twelve month low of $256.89 and a twelve month high of $350.00. The business has a 50 day moving average price of $299.22 and a two-hundred day moving average price of $307.62. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio is currently 32.97%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Guggenheim reiterated a “buy” rating and issued a $350.00 price target (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Wells Fargo & Company upped their target price on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Finally, Barclays lifted their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $369.89.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.